JPRN-UMIN000001324未知未知
Kyushu pitavastatin and pravastatin Intervention trial on Diabetic NEphropathY - Kyushu pitavastatin and pravastatin Intervention trial on Diabetic NEphropathY
Kyushu University Graduate School of Medical Science Department of Medicine and Bioregulatory Science0 个研究点目标入组 100 人开始时间: 2008年8月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1."Contraindications""Relative Contraindications""Absolute Contraindications for Coadministration" and "Relative Contraindications for Coadministration" for pitavastatin or pravastatin 2.Patients with hypothyroidism or inherited muscle disorder (muscular dystrophy etc.) and patients with a previous history of drug-induced myopathy 3.Non- diabetic nephropathy 4. Renal dysfunction (s-Cr over 1.5 mg/dl) 5.Urinary tract infection 6.Uncontrolled diabetes, defined as HbA1c>10.0% 7.Malignancy 8. Stroke 9. Heart failure (NYHA Class >= III) or myocardial infarction 10.Angina with symptom 11.Participating in clinical trials or clinical research 12.Judged as unsuitable for participating in this study by the attending physician
研究者
相似试验
已完成
不适用
Extended Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (Extended JAPAN-ACS)acute coronary syndromeJPRN-UMIN000003166Research Institute for Production Development252
已完成
不适用
Pitavastatin or bezafibrate intervention, assessment of antiarteriosclerotic effect (PIONEER)Type 2b hyperlipidemiaJPRN-UMIN000001130The Research group for Arteriosclerosis treatment of The supporting Center for Clinical Research and Education : SCCRE, a nonprofit organization150
招募中
不适用
Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on glucose metabolism compared to AtoRvastatin in atheroscLerotic cardiovascular disease patients with metabolic syndrome: The EZ-PEARL Randomized TrialDiseases of the circulatory systemKCT0008172Yonsei University Health System, Severance Hospital250
已完成
4 期
Yokohama Assessment of Fluvastatin, Pravastatin, Pitavastatin and Atorvastatin in Acute Coronary Syndrome (Yokohama-ACS)Coronary DiseaseHypercholesterolemiaNCT00549926Yokohama City University Medical Center200
进行中（未招募）
Unknown
Safety and Effectiveness of pravastatin in Korean patients with dyslipidemia based on the cardiovascular risk classification: Pooled analysis of 4 observational studiesEndocrine, nutritional and metabolic diseasesKCT0009357Daiichi-Sankyo Korea15,475